Patent ID: 7390503

Claim:
A non-effervescent, orally disintegrating, solid dosage form comprising: ondansetron in a concentration of about 1 to about 10% by weight of said dosage form; mannitol in a concentration of about 1% to about 60% by weight of said dosage form; xylitol in a concentration of about 1% to about 20% by weight of said dosage form; crospovidone in a concentration of about 1% to about 40% by weight of said dosage form; microcrystalline cellulose in a concentration of about 1% to about 10% by weight of said dosage form; and a hydrophobic lubricant in a concentration of up to about 10% by weight of said dosage form; wherein said dosage form is not freeze-dried; and wherein the time taken for disintegration of the dosage form in water or in saliva is within 60 seconds.